Catherine A. Sohn - Net Worth and Insider Trading
Catherine A. Sohn Net Worth
The estimated net worth of Catherine A. Sohn is at least $2 Million dollars as of 2024-11-10. Catherine A. Sohn is the Director of Jazz Pharmaceuticals PLC and owns about 14,868 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $2 Million. Catherine A. Sohn is the Director of Lifecore Biomedical Inc and owns about 25,091 shares of Lifecore Biomedical Inc (LFCR) stock worth over $169,113. Catherine A. Sohn is also the Director of Rubius Therapeutics Inc and owns about 2,500 shares of Rubius Therapeutics Inc (RUBY) stock worth over $143. Besides these, Catherine A. Sohn also holds Axcella Health Inc (AXLA) . Details can be seen in Catherine A. Sohn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Catherine A. Sohn has not made any transactions after 2023-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Catherine A. Sohn
Catherine A. Sohn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Catherine A. Sohn owns 7 companies in total, including Lifecore Biomedical Inc (LFCR) , Jazz Pharmaceuticals PLC (JAZZ) , and Rubius Therapeutics Inc (RUBY) among others .
Click here to see the complete history of Catherine A. Sohn’s form 4 insider trades.
Insider Ownership Summary of Catherine A. Sohn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LFCR | Lifecore Biomedical Inc | 2019-01-10 | director |
| JAZZ | Jazz Pharmaceuticals PLC | 2023-08-14 | director |
| RUBY | Rubius Therapeutics Inc | 2018-07-20 | director |
 | | 2020-01-17 | director |
| | 2015-07-01 | director |
| | 2014-01-13 | director |
| | 2023-03-23 | director |
Catherine A. Sohn Latest Holdings Summary
Catherine A. Sohn currently owns a total of 4 stocks. Among these stocks, Catherine A. Sohn owns 14,868 shares of Jazz Pharmaceuticals PLC (JAZZ) as of August 14, 2023, with a value of $2 Million and a weighting of 91.57%. Catherine A. Sohn owns 25,091 shares of Lifecore Biomedical Inc (LFCR) as of January 10, 2019, with a value of $169,113 and a weighting of 8.43%. Catherine A. Sohn also owns 2,500 shares of Rubius Therapeutics Inc (RUBY) as of July 20, 2018, with a value of $143 and a weighting of 0.01%. The other 1 stocks Axcella Health Inc (AXLA) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Catherine A. Sohn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 2023-08-14 | 14,868 | 123.62 | 1,837,982 |
| LFCR | Lifecore Biomedical Inc | 2019-01-10 | 25,091 | 6.74 | 169,113 |
| RUBY | Rubius Therapeutics Inc | 2018-07-20 | 2,500 | 0.06 | 143 |
| AXLA | Axcella Health Inc | 2020-01-17 | 40 | 0.40 | 16 |
Holding Weightings of Catherine A. Sohn
Catherine A. Sohn Form 4 Trading Tracker
According to the SEC Form 4 filings, Catherine A. Sohn has made a total of 5 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 1,241 shares on August 14, 2023, which brought Catherine A. Sohn around $171,457.
According to the SEC Form 4 filings, Catherine A. Sohn has made a total of 0 transactions in Lifecore Biomedical Inc (LFCR) over the past 5 years. The most-recent trade in Lifecore Biomedical Inc is the acquisition of 1,000 shares on January 10, 2019, which cost Catherine A. Sohn around $11,230.
According to the SEC Form 4 filings, Catherine A. Sohn has made a total of 0 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years. The most-recent trade in Rubius Therapeutics Inc is the acquisition of 2,500 shares on July 20, 2018, which cost Catherine A. Sohn around $57,500.
More details on Catherine A. Sohn's insider transactions can be found in the Insider Trading History of Catherine A. Sohn table.Insider Trading History of Catherine A. Sohn
- 1
Catherine A. Sohn Trading Performance
GuruFocus tracks the stock performance after each of Catherine A. Sohn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Catherine A. Sohn is -24.98%. GuruFocus also compares Catherine A. Sohn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Catherine A. Sohn within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Catherine A. Sohn's insider trading performs compared to the benchmark.
Performance of Catherine A. Sohn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.86 | | | | | |
| Relative Return to S&P 500(%) | -7.45 | | | | | |
Catherine A. Sohn Ownership Network
Ownership Network List of Catherine A. Sohn
Ownership Network Relation of Catherine A. Sohn
Catherine A. Sohn Owned Company Details
What does Lifecore Biomedical Inc do?
Who are the key executives at Lifecore Biomedical Inc?
Catherine A. Sohn is the director of Lifecore Biomedical Inc. Other key executives at Lifecore Biomedical Inc include 10 percent owner Wynnefield Partners Small Cap Value Lp I , Chief Financial Officer John D Morberg , and Executive Vice President James G Hall .
Lifecore Biomedical Inc (LFCR) Insider Trades Summary
Over the past 18 months, Catherine A. Sohn made no insider transaction in Lifecore Biomedical Inc (LFCR). Other recent insider transactions involving Lifecore Biomedical Inc (LFCR) include a net purchase of 1,463,414 shares made by Christopher S Kiper , and a net purchase of 292,683 shares made by Wynnefield Partners Small Cap Value Lp I .
In summary, during the past 3 months, insiders sold 0 shares of Lifecore Biomedical Inc (LFCR) in total and bought 1,756,097 shares, with a net purchase of 1,756,097 shares. During the past 18 months, 0 shares of Lifecore Biomedical Inc (LFCR) were sold and 1,756,097 shares were bought by its insiders, resulting in a net purchase of 1,756,097 shares.
Lifecore Biomedical Inc (LFCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lifecore Biomedical Inc Insider Transactions
Catherine A. Sohn Mailing Address
Above is the net worth, insider trading, and ownership report for Catherine A. Sohn. You might contact Catherine A. Sohn via mailing address: C/o Jazz Pharmaceuticals Plc, 5th Fl, Waterloo Exchange, Waterloo Rd, Dublin L2 4 L2.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
